TB-500 has a longer plasma half-life of approximately 2-3 hours due to its larger molecular size (~4963 g/mol) and slower clearance
Multiple procedures may be needed, and results may vary from person to person
This is a great opportunity for the FDA and EMA to revise the drug development pipeline to make it more flexible and less time-consuming
Change in how much or how often you urinate, lower back or side pain, blood in your urine Unusual moods or behaviors, depression, thoughts of hurting yourself or others Blurred vision or any other change in vision Sudden and severe stomach pain, constipation, diarrhea, nausea, vomiting, fever, passing gas, stomach upset or bloating, yellow eyes or skin Shaking, trembling, sweating, fast or pounding heartbeat, lightheadedness, hunger, confusion Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing Tell your doctor if you are breastfeeding, or if you have kidney disease, pancreas problems, diabetes, digestion problems (including gastroparesis), or a history of diabetic retinopathy or depression
The 500 Dalton rule (molecular weight below 500 Da correlates with percutaneous absorption) is a necessary but not sufficient condition, not a guarantee
